Global Arbidol Tablets (COVID-19) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Arbidol Hydrochloride as known as Arbidol, is an antiviral treatment for influenza infection.
According to our (Global Info Research) latest study, the global Arbidol Tablets (COVID-19) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In February 2020, Li Lanjuan, an expert of the National Health Commission of China, proposed using Arbidol (umifenovir) together with darunavir as a potential treatment during the 2019–20 coronavirus outbreak. Chinese experts claim that preliminary tests had shown that arbidol and darunavir could inhibit replication of the virus. However, later studies showed that it did not show any efficacy in treating the Covid-19 disease. However usage by itself as a post-exposure prophylaxis (PEP) of Covid-19 transmission has been demonstrating positive results though further research is still warranted.
This report is a detailed and comprehensive analysis for global Arbidol Tablets (COVID-19) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Arbidol Tablets (COVID-19) market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/K Pcs), 2018-2029
Global Arbidol Tablets (COVID-19) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/K Pcs), 2018-2029
Global Arbidol Tablets (COVID-19) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/K Pcs), 2018-2029
Global Arbidol Tablets (COVID-19) market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (US$/K Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Arbidol Tablets (COVID-19)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Arbidol Tablets (COVID-19) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JSC Pharmstandard, Jiangsu Wuzhong Pharmaceutical, CSPC Ouyi Pharmaceutical and Simcere Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Arbidol Tablets (COVID-19) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Arbidol Tablets (COVID-19) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Arbidol Tablets (COVID-19), with price, sales, revenue and global market share of Arbidol Tablets (COVID-19) from 2018 to 2023.
Chapter 3, the Arbidol Tablets (COVID-19) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Arbidol Tablets (COVID-19) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Arbidol Tablets (COVID-19) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Arbidol Tablets (COVID-19).
Chapter 14 and 15, to describe Arbidol Tablets (COVID-19) sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Arbidol Tablets (COVID-19) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In February 2020, Li Lanjuan, an expert of the National Health Commission of China, proposed using Arbidol (umifenovir) together with darunavir as a potential treatment during the 2019–20 coronavirus outbreak. Chinese experts claim that preliminary tests had shown that arbidol and darunavir could inhibit replication of the virus. However, later studies showed that it did not show any efficacy in treating the Covid-19 disease. However usage by itself as a post-exposure prophylaxis (PEP) of Covid-19 transmission has been demonstrating positive results though further research is still warranted.
This report is a detailed and comprehensive analysis for global Arbidol Tablets (COVID-19) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Arbidol Tablets (COVID-19) market size and forecasts, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/K Pcs), 2018-2029
Global Arbidol Tablets (COVID-19) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/K Pcs), 2018-2029
Global Arbidol Tablets (COVID-19) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Pcs), and average selling prices (US$/K Pcs), 2018-2029
Global Arbidol Tablets (COVID-19) market shares of main players, shipments in revenue ($ Million), sales quantity (M Pcs), and ASP (US$/K Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Arbidol Tablets (COVID-19)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Arbidol Tablets (COVID-19) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JSC Pharmstandard, Jiangsu Wuzhong Pharmaceutical, CSPC Ouyi Pharmaceutical and Simcere Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Arbidol Tablets (COVID-19) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 50mg
- 100mg
- Anti Influenza Virus
- COVID-19
- JSC Pharmstandard
- Jiangsu Wuzhong Pharmaceutical
- CSPC Ouyi Pharmaceutical
- Simcere Pharmaceutical
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Arbidol Tablets (COVID-19) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Arbidol Tablets (COVID-19), with price, sales, revenue and global market share of Arbidol Tablets (COVID-19) from 2018 to 2023.
Chapter 3, the Arbidol Tablets (COVID-19) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Arbidol Tablets (COVID-19) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Arbidol Tablets (COVID-19) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Arbidol Tablets (COVID-19).
Chapter 14 and 15, to describe Arbidol Tablets (COVID-19) sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Arbidol Tablets (COVID-19)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Arbidol Tablets (COVID-19) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50mg
1.3.3 100mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Arbidol Tablets (COVID-19) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Anti Influenza Virus
1.4.3 COVID-19
1.5 Global Arbidol Tablets (COVID-19) Market Size & Forecast
1.5.1 Global Arbidol Tablets (COVID-19) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Arbidol Tablets (COVID-19) Sales Quantity (2018-2029)
1.5.3 Global Arbidol Tablets (COVID-19) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 JSC Pharmstandard
2.1.1 JSC Pharmstandard Details
2.1.2 JSC Pharmstandard Major Business
2.1.3 JSC Pharmstandard Arbidol Tablets (COVID-19) Product and Services
2.1.4 JSC Pharmstandard Arbidol Tablets (COVID-19) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 JSC Pharmstandard Recent Developments/Updates
2.2 Jiangsu Wuzhong Pharmaceutical
2.2.1 Jiangsu Wuzhong Pharmaceutical Details
2.2.2 Jiangsu Wuzhong Pharmaceutical Major Business
2.2.3 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
2.2.4 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
2.3 CSPC Ouyi Pharmaceutical
2.3.1 CSPC Ouyi Pharmaceutical Details
2.3.2 CSPC Ouyi Pharmaceutical Major Business
2.3.3 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
2.3.4 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
2.4 Simcere Pharmaceutical
2.4.1 Simcere Pharmaceutical Details
2.4.2 Simcere Pharmaceutical Major Business
2.4.3 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
2.4.4 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Simcere Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ARBIDOL TABLETS (COVID-19) BY MANUFACTURER
3.1 Global Arbidol Tablets (COVID-19) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Arbidol Tablets (COVID-19) Revenue by Manufacturer (2018-2023)
3.3 Global Arbidol Tablets (COVID-19) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Arbidol Tablets (COVID-19) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Arbidol Tablets (COVID-19) Manufacturer Market Share in 2022
3.4.2 Top 6 Arbidol Tablets (COVID-19) Manufacturer Market Share in 2022
3.5 Arbidol Tablets (COVID-19) Market: Overall Company Footprint Analysis
3.5.1 Arbidol Tablets (COVID-19) Market: Region Footprint
3.5.2 Arbidol Tablets (COVID-19) Market: Company Product Type Footprint
3.5.3 Arbidol Tablets (COVID-19) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Arbidol Tablets (COVID-19) Market Size by Region
4.1.1 Global Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2029)
4.1.2 Global Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2029)
4.1.3 Global Arbidol Tablets (COVID-19) Average Price by Region (2018-2029)
4.2 North America Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
4.3 Europe Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
4.4 Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
4.5 South America Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
4.6 Middle East and Africa Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
5.2 Global Arbidol Tablets (COVID-19) Consumption Value by Type (2018-2029)
5.3 Global Arbidol Tablets (COVID-19) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
6.2 Global Arbidol Tablets (COVID-19) Consumption Value by Application (2018-2029)
6.3 Global Arbidol Tablets (COVID-19) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
7.2 North America Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
7.3 North America Arbidol Tablets (COVID-19) Market Size by Country
7.3.1 North America Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2029)
7.3.2 North America Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
8.2 Europe Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
8.3 Europe Arbidol Tablets (COVID-19) Market Size by Country
8.3.1 Europe Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2029)
8.3.2 Europe Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Arbidol Tablets (COVID-19) Market Size by Region
9.3.1 Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
10.2 South America Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
10.3 South America Arbidol Tablets (COVID-19) Market Size by Country
10.3.1 South America Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2029)
10.3.2 South America Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Arbidol Tablets (COVID-19) Market Size by Country
11.3.1 Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Arbidol Tablets (COVID-19) Market Drivers
12.2 Arbidol Tablets (COVID-19) Market Restraints
12.3 Arbidol Tablets (COVID-19) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Arbidol Tablets (COVID-19) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Arbidol Tablets (COVID-19)
13.3 Arbidol Tablets (COVID-19) Production Process
13.4 Arbidol Tablets (COVID-19) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Arbidol Tablets (COVID-19) Typical Distributors
14.3 Arbidol Tablets (COVID-19) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Arbidol Tablets (COVID-19)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Arbidol Tablets (COVID-19) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50mg
1.3.3 100mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Arbidol Tablets (COVID-19) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Anti Influenza Virus
1.4.3 COVID-19
1.5 Global Arbidol Tablets (COVID-19) Market Size & Forecast
1.5.1 Global Arbidol Tablets (COVID-19) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Arbidol Tablets (COVID-19) Sales Quantity (2018-2029)
1.5.3 Global Arbidol Tablets (COVID-19) Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 JSC Pharmstandard
2.1.1 JSC Pharmstandard Details
2.1.2 JSC Pharmstandard Major Business
2.1.3 JSC Pharmstandard Arbidol Tablets (COVID-19) Product and Services
2.1.4 JSC Pharmstandard Arbidol Tablets (COVID-19) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 JSC Pharmstandard Recent Developments/Updates
2.2 Jiangsu Wuzhong Pharmaceutical
2.2.1 Jiangsu Wuzhong Pharmaceutical Details
2.2.2 Jiangsu Wuzhong Pharmaceutical Major Business
2.2.3 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
2.2.4 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
2.3 CSPC Ouyi Pharmaceutical
2.3.1 CSPC Ouyi Pharmaceutical Details
2.3.2 CSPC Ouyi Pharmaceutical Major Business
2.3.3 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
2.3.4 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
2.4 Simcere Pharmaceutical
2.4.1 Simcere Pharmaceutical Details
2.4.2 Simcere Pharmaceutical Major Business
2.4.3 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
2.4.4 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Simcere Pharmaceutical Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ARBIDOL TABLETS (COVID-19) BY MANUFACTURER
3.1 Global Arbidol Tablets (COVID-19) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Arbidol Tablets (COVID-19) Revenue by Manufacturer (2018-2023)
3.3 Global Arbidol Tablets (COVID-19) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Arbidol Tablets (COVID-19) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Arbidol Tablets (COVID-19) Manufacturer Market Share in 2022
3.4.2 Top 6 Arbidol Tablets (COVID-19) Manufacturer Market Share in 2022
3.5 Arbidol Tablets (COVID-19) Market: Overall Company Footprint Analysis
3.5.1 Arbidol Tablets (COVID-19) Market: Region Footprint
3.5.2 Arbidol Tablets (COVID-19) Market: Company Product Type Footprint
3.5.3 Arbidol Tablets (COVID-19) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Arbidol Tablets (COVID-19) Market Size by Region
4.1.1 Global Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2029)
4.1.2 Global Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2029)
4.1.3 Global Arbidol Tablets (COVID-19) Average Price by Region (2018-2029)
4.2 North America Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
4.3 Europe Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
4.4 Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
4.5 South America Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
4.6 Middle East and Africa Arbidol Tablets (COVID-19) Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
5.2 Global Arbidol Tablets (COVID-19) Consumption Value by Type (2018-2029)
5.3 Global Arbidol Tablets (COVID-19) Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
6.2 Global Arbidol Tablets (COVID-19) Consumption Value by Application (2018-2029)
6.3 Global Arbidol Tablets (COVID-19) Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
7.2 North America Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
7.3 North America Arbidol Tablets (COVID-19) Market Size by Country
7.3.1 North America Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2029)
7.3.2 North America Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
8.2 Europe Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
8.3 Europe Arbidol Tablets (COVID-19) Market Size by Country
8.3.1 Europe Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2029)
8.3.2 Europe Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Arbidol Tablets (COVID-19) Market Size by Region
9.3.1 Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
10.2 South America Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
10.3 South America Arbidol Tablets (COVID-19) Market Size by Country
10.3.1 South America Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2029)
10.3.2 South America Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Arbidol Tablets (COVID-19) Market Size by Country
11.3.1 Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Arbidol Tablets (COVID-19) Market Drivers
12.2 Arbidol Tablets (COVID-19) Market Restraints
12.3 Arbidol Tablets (COVID-19) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Arbidol Tablets (COVID-19) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Arbidol Tablets (COVID-19)
13.3 Arbidol Tablets (COVID-19) Production Process
13.4 Arbidol Tablets (COVID-19) Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Arbidol Tablets (COVID-19) Typical Distributors
14.3 Arbidol Tablets (COVID-19) Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Arbidol Tablets (COVID-19) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Arbidol Tablets (COVID-19) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. JSC Pharmstandard Basic Information, Manufacturing Base and Competitors
Table 4. JSC Pharmstandard Major Business
Table 5. JSC Pharmstandard Arbidol Tablets (COVID-19) Product and Services
Table 6. JSC Pharmstandard Arbidol Tablets (COVID-19) Sales Quantity (M Pcs), Average Price (US$/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. JSC Pharmstandard Recent Developments/Updates
Table 8. Jiangsu Wuzhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Jiangsu Wuzhong Pharmaceutical Major Business
Table 10. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
Table 11. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity (M Pcs), Average Price (US$/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
Table 13. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. CSPC Ouyi Pharmaceutical Major Business
Table 15. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
Table 16. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity (M Pcs), Average Price (US$/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 18. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Simcere Pharmaceutical Major Business
Table 20. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
Table 21. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity (M Pcs), Average Price (US$/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Simcere Pharmaceutical Recent Developments/Updates
Table 23. Global Arbidol Tablets (COVID-19) Sales Quantity by Manufacturer (2018-2023) & (M Pcs)
Table 24. Global Arbidol Tablets (COVID-19) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Arbidol Tablets (COVID-19) Average Price by Manufacturer (2018-2023) & (US$/K Pcs)
Table 26. Market Position of Manufacturers in Arbidol Tablets (COVID-19), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Arbidol Tablets (COVID-19) Production Site of Key Manufacturer
Table 28. Arbidol Tablets (COVID-19) Market: Company Product Type Footprint
Table 29. Arbidol Tablets (COVID-19) Market: Company Product Application Footprint
Table 30. Arbidol Tablets (COVID-19) New Market Entrants and Barriers to Market Entry
Table 31. Arbidol Tablets (COVID-19) Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2023) & (M Pcs)
Table 33. Global Arbidol Tablets (COVID-19) Sales Quantity by Region (2024-2029) & (M Pcs)
Table 34. Global Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Arbidol Tablets (COVID-19) Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Arbidol Tablets (COVID-19) Average Price by Region (2018-2023) & (US$/K Pcs)
Table 37. Global Arbidol Tablets (COVID-19) Average Price by Region (2024-2029) & (US$/K Pcs)
Table 38. Global Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 39. Global Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 40. Global Arbidol Tablets (COVID-19) Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Arbidol Tablets (COVID-19) Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Arbidol Tablets (COVID-19) Average Price by Type (2018-2023) & (US$/K Pcs)
Table 43. Global Arbidol Tablets (COVID-19) Average Price by Type (2024-2029) & (US$/K Pcs)
Table 44. Global Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 45. Global Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 46. Global Arbidol Tablets (COVID-19) Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Arbidol Tablets (COVID-19) Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Arbidol Tablets (COVID-19) Average Price by Application (2018-2023) & (US$/K Pcs)
Table 49. Global Arbidol Tablets (COVID-19) Average Price by Application (2024-2029) & (US$/K Pcs)
Table 50. North America Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 51. North America Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 52. North America Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 53. North America Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 54. North America Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2023) & (M Pcs)
Table 55. North America Arbidol Tablets (COVID-19) Sales Quantity by Country (2024-2029) & (M Pcs)
Table 56. North America Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Arbidol Tablets (COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 59. Europe Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 60. Europe Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 61. Europe Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 62. Europe Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2023) & (M Pcs)
Table 63. Europe Arbidol Tablets (COVID-19) Sales Quantity by Country (2024-2029) & (M Pcs)
Table 64. Europe Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Arbidol Tablets (COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 67. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 68. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 69. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 70. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2023) & (M Pcs)
Table 71. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Region (2024-2029) & (M Pcs)
Table 72. Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 75. South America Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 76. South America Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 77. South America Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 78. South America Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2023) & (M Pcs)
Table 79. South America Arbidol Tablets (COVID-19) Sales Quantity by Country (2024-2029) & (M Pcs)
Table 80. South America Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Arbidol Tablets (COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 83. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 84. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 85. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 86. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2023) & (M Pcs)
Table 87. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Region (2024-2029) & (M Pcs)
Table 88. Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Arbidol Tablets (COVID-19) Raw Material
Table 91. Key Manufacturers of Arbidol Tablets (COVID-19) Raw Materials
Table 92. Arbidol Tablets (COVID-19) Typical Distributors
Table 93. Arbidol Tablets (COVID-19) Typical Customers
Table 1. Global Arbidol Tablets (COVID-19) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Arbidol Tablets (COVID-19) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. JSC Pharmstandard Basic Information, Manufacturing Base and Competitors
Table 4. JSC Pharmstandard Major Business
Table 5. JSC Pharmstandard Arbidol Tablets (COVID-19) Product and Services
Table 6. JSC Pharmstandard Arbidol Tablets (COVID-19) Sales Quantity (M Pcs), Average Price (US$/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. JSC Pharmstandard Recent Developments/Updates
Table 8. Jiangsu Wuzhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 9. Jiangsu Wuzhong Pharmaceutical Major Business
Table 10. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
Table 11. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity (M Pcs), Average Price (US$/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
Table 13. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. CSPC Ouyi Pharmaceutical Major Business
Table 15. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
Table 16. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity (M Pcs), Average Price (US$/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 18. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Simcere Pharmaceutical Major Business
Table 20. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product and Services
Table 21. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales Quantity (M Pcs), Average Price (US$/K Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Simcere Pharmaceutical Recent Developments/Updates
Table 23. Global Arbidol Tablets (COVID-19) Sales Quantity by Manufacturer (2018-2023) & (M Pcs)
Table 24. Global Arbidol Tablets (COVID-19) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Arbidol Tablets (COVID-19) Average Price by Manufacturer (2018-2023) & (US$/K Pcs)
Table 26. Market Position of Manufacturers in Arbidol Tablets (COVID-19), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Arbidol Tablets (COVID-19) Production Site of Key Manufacturer
Table 28. Arbidol Tablets (COVID-19) Market: Company Product Type Footprint
Table 29. Arbidol Tablets (COVID-19) Market: Company Product Application Footprint
Table 30. Arbidol Tablets (COVID-19) New Market Entrants and Barriers to Market Entry
Table 31. Arbidol Tablets (COVID-19) Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2023) & (M Pcs)
Table 33. Global Arbidol Tablets (COVID-19) Sales Quantity by Region (2024-2029) & (M Pcs)
Table 34. Global Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Arbidol Tablets (COVID-19) Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Arbidol Tablets (COVID-19) Average Price by Region (2018-2023) & (US$/K Pcs)
Table 37. Global Arbidol Tablets (COVID-19) Average Price by Region (2024-2029) & (US$/K Pcs)
Table 38. Global Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 39. Global Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 40. Global Arbidol Tablets (COVID-19) Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Arbidol Tablets (COVID-19) Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Arbidol Tablets (COVID-19) Average Price by Type (2018-2023) & (US$/K Pcs)
Table 43. Global Arbidol Tablets (COVID-19) Average Price by Type (2024-2029) & (US$/K Pcs)
Table 44. Global Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 45. Global Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 46. Global Arbidol Tablets (COVID-19) Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Arbidol Tablets (COVID-19) Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Arbidol Tablets (COVID-19) Average Price by Application (2018-2023) & (US$/K Pcs)
Table 49. Global Arbidol Tablets (COVID-19) Average Price by Application (2024-2029) & (US$/K Pcs)
Table 50. North America Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 51. North America Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 52. North America Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 53. North America Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 54. North America Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2023) & (M Pcs)
Table 55. North America Arbidol Tablets (COVID-19) Sales Quantity by Country (2024-2029) & (M Pcs)
Table 56. North America Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Arbidol Tablets (COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 59. Europe Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 60. Europe Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 61. Europe Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 62. Europe Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2023) & (M Pcs)
Table 63. Europe Arbidol Tablets (COVID-19) Sales Quantity by Country (2024-2029) & (M Pcs)
Table 64. Europe Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Arbidol Tablets (COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 67. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 68. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 69. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 70. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2023) & (M Pcs)
Table 71. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity by Region (2024-2029) & (M Pcs)
Table 72. Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 75. South America Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 76. South America Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 77. South America Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 78. South America Arbidol Tablets (COVID-19) Sales Quantity by Country (2018-2023) & (M Pcs)
Table 79. South America Arbidol Tablets (COVID-19) Sales Quantity by Country (2024-2029) & (M Pcs)
Table 80. South America Arbidol Tablets (COVID-19) Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Arbidol Tablets (COVID-19) Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Type (2018-2023) & (M Pcs)
Table 83. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Type (2024-2029) & (M Pcs)
Table 84. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Application (2018-2023) & (M Pcs)
Table 85. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Application (2024-2029) & (M Pcs)
Table 86. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Region (2018-2023) & (M Pcs)
Table 87. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity by Region (2024-2029) & (M Pcs)
Table 88. Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Arbidol Tablets (COVID-19) Raw Material
Table 91. Key Manufacturers of Arbidol Tablets (COVID-19) Raw Materials
Table 92. Arbidol Tablets (COVID-19) Typical Distributors
Table 93. Arbidol Tablets (COVID-19) Typical Customers
LIST OF FIGURES
Figure 1. Arbidol Tablets (COVID-19) Picture
Figure 2. Global Arbidol Tablets (COVID-19) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Type in 2022
Figure 4. 50mg Examples
Figure 5. 100mg Examples
Figure 6. Global Arbidol Tablets (COVID-19) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Application in 2022
Figure 8. Anti Influenza Virus Examples
Figure 9. COVID-19 Examples
Figure 10. Global Arbidol Tablets (COVID-19) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Arbidol Tablets (COVID-19) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Arbidol Tablets (COVID-19) Sales Quantity (2018-2029) & (M Pcs)
Figure 13. Global Arbidol Tablets (COVID-19) Average Price (2018-2029) & (US$/K Pcs)
Figure 14. Global Arbidol Tablets (COVID-19) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Arbidol Tablets (COVID-19) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Arbidol Tablets (COVID-19) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Arbidol Tablets (COVID-19) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Arbidol Tablets (COVID-19) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Arbidol Tablets (COVID-19) Average Price by Type (2018-2029) & (US$/K Pcs)
Figure 29. Global Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Arbidol Tablets (COVID-19) Average Price by Application (2018-2029) & (US$/K Pcs)
Figure 32. North America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Arbidol Tablets (COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Arbidol Tablets (COVID-19) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Arbidol Tablets (COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Arbidol Tablets (COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Arbidol Tablets (COVID-19) Market Drivers
Figure 73. Arbidol Tablets (COVID-19) Market Restraints
Figure 74. Arbidol Tablets (COVID-19) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Arbidol Tablets (COVID-19) in 2022
Figure 77. Manufacturing Process Analysis of Arbidol Tablets (COVID-19)
Figure 78. Arbidol Tablets (COVID-19) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Arbidol Tablets (COVID-19) Picture
Figure 2. Global Arbidol Tablets (COVID-19) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Type in 2022
Figure 4. 50mg Examples
Figure 5. 100mg Examples
Figure 6. Global Arbidol Tablets (COVID-19) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Application in 2022
Figure 8. Anti Influenza Virus Examples
Figure 9. COVID-19 Examples
Figure 10. Global Arbidol Tablets (COVID-19) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Arbidol Tablets (COVID-19) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Arbidol Tablets (COVID-19) Sales Quantity (2018-2029) & (M Pcs)
Figure 13. Global Arbidol Tablets (COVID-19) Average Price (2018-2029) & (US$/K Pcs)
Figure 14. Global Arbidol Tablets (COVID-19) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Arbidol Tablets (COVID-19) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Arbidol Tablets (COVID-19) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Arbidol Tablets (COVID-19) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Arbidol Tablets (COVID-19) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Arbidol Tablets (COVID-19) Average Price by Type (2018-2029) & (US$/K Pcs)
Figure 29. Global Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Arbidol Tablets (COVID-19) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Arbidol Tablets (COVID-19) Average Price by Application (2018-2029) & (US$/K Pcs)
Figure 32. North America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Arbidol Tablets (COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Arbidol Tablets (COVID-19) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Arbidol Tablets (COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Arbidol Tablets (COVID-19) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Arbidol Tablets (COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Arbidol Tablets (COVID-19) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Arbidol Tablets (COVID-19) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Arbidol Tablets (COVID-19) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Arbidol Tablets (COVID-19) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Arbidol Tablets (COVID-19) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Arbidol Tablets (COVID-19) Market Drivers
Figure 73. Arbidol Tablets (COVID-19) Market Restraints
Figure 74. Arbidol Tablets (COVID-19) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Arbidol Tablets (COVID-19) in 2022
Figure 77. Manufacturing Process Analysis of Arbidol Tablets (COVID-19)
Figure 78. Arbidol Tablets (COVID-19) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
